// App-Quantinova.ai

2925 : Economic Evaluation of Damage Accrual in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

Researchers

Presenter

  • Ann E. Clarke

Principal Investigators

  • Murray Urowitz

  • John G. Hanly

  • Yvan St.Pierre

  • Sang-Cheol Bae

  • Sasha Bernatsky

  • Dafna D Gladman

  • Jorge Sanchez-Guerrero

  • Paul R. Fortin

  • Juanita Romero-Diaz

  • Michelle Petri

  • Rosalind Ramsey-Goldman

  • Cynthia Aranow

  • Sren Jacobsen

  • Daniel J. Wallace

  • Joan T. Merrill

  • S. Sam Lim

  • Ola Nived

  • Andreas Jnsen

  • Susan Manzi

  • Thomas Stoll

  • Christine A. Peschken

  • David A. Isenberg

  • Anisur Rahman

  • Li Su

  • Vernon Farewell

Medical Centers

  • Division of Nephrology, University of Calgary, Calgary, AB, Canada

  • Central Manchester University Hospital NHS Foundation Trust and Manchester Academic Health Science Centre, Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester Academic Health Sciences Centre, Manchester, United Kingdom

  • Centre for Prognosis Studies in the Rheumatic Diseases, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada

  • Nova Scotia Rehab Site, Division of Rheumatology, Capital Health and Dalhousie University, Halifax, NS, Canada

  • McGill University Health Centre, Montreal, QC, Canada

  • Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea

  • Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada

  • Centre for Prognosis Studies in the Rheumatic Diseases, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada

  • Division of Gastroenterology, Mount Sinai Hospital, Toronto, Ontario, Canada

  • CHU de Quebec - Universite Laval, Quebec City, QC, Canada

  • Immunology and Rheumatology, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico city, Mexico

  • Division of Rheumatology, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD

  • Northwestern University, Chicago, IL

  • Center for Autoimmune and Musculoskeletal Diseases, The Feinstein Institute for Medical Research, Manhasset, NY

  • NSGO & Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark

  • Cedars-Sinai Medical Center, Beverly Hills, CA

  • Oklahoma Medical Research Foundation, Oklahoma city, OK.

  • Medicine/Rheumatology, Emory University School of Medicine, Atlanta, GA

  • Dept. of Hematology, University Hospital, Lund, Sweden

  • Lund University, Department of Clinical Sciences Lund, Rheumatology, Lund, Sweden, Lund, Sweden

  • Allegheny Health Network, Pittsburgh, PA

  • Abteilung Rheumatologie/Rehab, Kantonsspital Schaffhausen, Schaffhausen, Switzerland

  • University of Mantioba, Winnipeg, MB, Canada

  • Centre for Rheumatology Research, UCL Division of Medicine, University College London, London, United Kingdom

  • Rayne Intitiute, Centre for Rheumatology Research, UCL Division of Medicine, London, United Kingdom

  • Nova Scotia Rehab Site, Division of Rheumatology, Capital Health and Dalhousie University, Halifax, NS, Canada

  • Nova Scotia Rehab Site, Division of Rheumatology, Capital Health and Dalhousie University, Halifax, NS, Canada

Locations

  • Canada

  • United Kingdom

  • Mexico

  • United States

  • Denmark

  • Sweden

  • Switzerland

  • Republic of South Korea

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved